Renaissance Technologies’s Connect Biopharma Holdings Limited Ordinary Shares CNTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Buy |
143,700
+28,900
| +25% | +$28.3K | ﹤0.01% | 3241 |
|
|
2025
Q1 | $63.1K | Sell |
114,800
-19,897
| -15% | -$10.9K | ﹤0.01% | 3264 |
|
|
2024
Q4 | $186K | Sell |
134,697
-40,803
| -23% | -$56.3K | ﹤0.01% | 3189 |
|
|
2024
Q3 | $253K | Sell |
175,500
-36,800
| -17% | -$53K | ﹤0.01% | 3045 |
|
|
2024
Q2 | $323K | Sell |
212,300
-27,600
| -12% | -$42K | ﹤0.01% | 2883 |
|
|
2024
Q1 | $417K | Sell |
239,900
-58,100
| -19% | -$101K | ﹤0.01% | 2938 |
|
|
2023
Q4 | $352K | Buy |
298,000
+201,000
| +207% | +$237K | ﹤0.01% | 2919 |
|
|
2023
Q3 | $79K | Buy |
97,000
+1,500
| +2% | +$1.22K | ﹤0.01% | 3295 |
|
|
2023
Q2 | $108K | Buy |
95,500
+6,400
| +7% | +$7.24K | ﹤0.01% | 3450 |
|
|
2023
Q1 | $89K | Buy |
89,100
+5,200
| +6% | +$5.19K | ﹤0.01% | 3523 |
|
|
2022
Q4 | $73K | Buy |
83,900
+600
| +0.7% | +$522 | ﹤0.01% | 3707 |
|
|
2022
Q3 | $107K | Buy |
83,300
+16,400
| +25% | +$21.1K | ﹤0.01% | 3575 |
|
|
2022
Q2 | $58K | Buy |
66,900
+43,400
| +185% | +$37.6K | ﹤0.01% | 3971 |
|
|
2022
Q1 | $71K | Buy |
23,500
+12,700
| +118% | +$38.4K | ﹤0.01% | 3850 |
|
|
2021
Q4 | $56K | Buy |
+10,800
| New | +$56K | ﹤0.01% | 3774 |
|